New DNA test could spot uterine cancer from a urine sample

NCT ID NCT07400835

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether DNA markers in urine, vaginal, and cervical samples can better identify endometrial cancer risk in women with postmenopausal bleeding. About 600 participants will provide samples and undergo standard ultrasound. The goal is to see if these non-invasive tests can reduce unnecessary biopsies and catch cancer earlier.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endometrial cancer endometrium neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Obstetrics and Gynaecology, Aarhus University Hospital

    RECRUITING

    Aarhus N, 8200, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Department of Obstetrics and Gynaecology, Odense University Hospital

    RECRUITING

    Odense, 5000, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Department of Obstetrics and Gynaecology, Randers Regional Hospital

    NOT_YET_RECRUITING

    Randers, 8930, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••